Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)

Technology appraisal guidance
Reference number: TA23
Published: 26 April 2001
Last updated: 03 March 2016

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive
11 May 2011
(63.07 Kb 18 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 May 2011